Anthony Z. Wang

ORCID: 0000-0003-4824-9908
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cancer Immunotherapy and Biomarkers
  • CAR-T cell therapy research
  • Immune Cell Function and Interaction
  • Glioma Diagnosis and Treatment
  • RNA modifications and cancer
  • Cancer Genomics and Diagnostics
  • Ferroptosis and cancer prognosis
  • Meningioma and schwannoma management
  • T-cell and B-cell Immunology
  • Single-cell and spatial transcriptomics
  • Neuroinflammation and Neurodegeneration Mechanisms
  • Immunotherapy and Immune Responses
  • interferon and immune responses
  • Mathematical Biology Tumor Growth
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Extracellular vesicles in disease
  • Bacterial Genetics and Biotechnology
  • Acute Myeloid Leukemia Research
  • Galectins and Cancer Biology
  • Gene Regulatory Network Analysis
  • Virus-based gene therapy research
  • Immune cells in cancer
  • Protein Tyrosine Phosphatases
  • DNA and Nucleic Acid Chemistry
  • Eosinophilic Disorders and Syndromes

Washington University in St. Louis
2021-2024

Massachusetts General Hospital
2022-2024

Harvard University
2023-2024

Neurological Surgery
2021-2023

Rice University
2019

Baylor College of Medicine
2018

Recent investigations of the meninges have highlighted importance dura layer in central nervous system immune surveillance beyond a purely structural role. However, our understanding largely stems from use pre-clinical models rather than human samples.

10.1186/s13073-022-01051-9 article EN cc-by Genome Medicine 2022-05-09

Recent clinical trials have highlighted the limited efficacy of T cell-based immunotherapy in patients with glioblastoma (GBM). To better understand characteristics tumor-infiltrating lymphocytes (TIL) GBM, we performed cellular indexing transcriptomes and epitopes by sequencing single-cell RNA paired V(D)J sequencing, respectively, on TILs from two cohorts totaling 15 high-grade glioma, including GBM or astrocytoma, IDH-mutant, grade 4 (G4A). Analysis CD8+ TIL landscape reveals an...

10.1158/2159-8290.cd-23-0913 article EN Cancer Discovery 2024-02-27

Abstract Despite some success in secondary brain metastases, targeted or immune-based therapies have shown limited efficacy against primary malignancies such as glioblastoma (GBM). Although the intratumoral heterogeneity of GBM is implicated treatment resistance, it remains unclear whether this diversity observed within metastases and to what extent cancer cell–intrinsic sculpts local immune microenvironment. Here, we profiled immunogenomic state 93 spatially distinct regions from 30...

10.1158/2159-8290.cd-21-0291 article EN cc-by-nc-nd Cancer Discovery 2021-10-05

The central nervous system (CNS) antigen-presenting cell (APC) that primes antitumor CD8+ T-cell responses remains undefined. Elsewhere in the body, conventional dendritic 1 (cDC1) performs this role. However, steady-state brain parenchyma cDC1 are extremely rare; cDCs localize to choroid plexus and dura. Thus, whether play a function presenting antigen derived from parenchymal sources tumor setting unknown. Using preclinical glioblastoma (GBM) models cDC1-deficient mice, we explored...

10.1158/2326-6066.cir-22-0098 article EN Cancer Immunology Research 2022-11-21

Treatment resistance in glioblastoma (GBM) is largely driven by the extensive multi-level heterogeneity that typifies this disease. Despite significant progress toward elucidating GBM's genomic and transcriptional heterogeneity, a critical knowledge gap remains defining at spatial level. To address this, we employed transcriptomics to map architecture of GBM ecosystem. This revealed tumor cell states are jointly defined gene expression localization, multicellular niches whose composition...

10.1101/2025.04.04.647096 preprint EN bioRxiv (Cold Spring Harbor Laboratory) 2025-04-04

Adoptive cellular therapies with chimeric antigen receptor T cells have revolutionized the treatment of some malignancies but shown limited efficacy in solid tumors such as glioblastoma and face a scarcity safe therapeutic targets. As an alternative, cell (TCR)-engineered therapy against tumor-specific neoantigens has generated significant excitement, there exist no preclinical systems to rigorously model this approach glioblastoma.

10.1136/jitc-2022-006121 article EN cc-by-nc Journal for ImmunoTherapy of Cancer 2023-02-01

The N protein of phage Mu was indicated from studies in Escherichia coli to hold linear chromosomes a circular conformation by non-covalent association, and thus suggested potentially bind DNA double-stranded ends. Because its role association with DNA, we tested whether fluorescent-protein fusions might provide useful tool for labeling damage including double-strand break (DSB) ends single cells. We compared N-GFP biochemically well documented DSB-end binding protein, the Gam Mu, also fused...

10.1016/j.dnarep.2018.09.005 article EN cc-by-nc-nd DNA repair 2018-09-14

Abstract Chronic myeloproliferative neoplasms (MPNs) exhibit a propensity for transformation to secondary acute myeloid leukemia (sAML), which the underlying mechanisms remain poorly understood, resulting in limited treatment options and dismal clinical outcomes. Here, we performed bulk transcriptome profiling accompanied by single cell RNA-sequencing on CD34+ stem/progenitor cells from serial patient samples obtained at chronic MPN sAML phases, identified aberrantly increased expression of...

10.1101/2021.06.27.449656 preprint EN cc-by-nc-nd bioRxiv (Cold Spring Harbor Laboratory) 2021-07-02

Abstract Recent investigation of the meninges, specifically dura layer, has highlighted its importance in CNS immune surveillance beyond a purely structural role. However, most our understanding meninges stems from use pre-clinical models rather than human samples. In this study, we single cell RNA-sequencing to perform first characterization both non-tumor-associated and meningioma First, reveal complex microenvironment that is transcriptionally distinct meningioma. addition, through T...

10.1101/2021.08.03.454066 preprint EN bioRxiv (Cold Spring Harbor Laboratory) 2021-08-03
Coming Soon ...